- Reuters•7 days ago
Medical device maker Integra LifeSciences Holdings Corp said it would buy Johnson & Johnson's Codman neurosurgery business for $1.05 billion in cash, to expand its presence outside the United States. Integra, which makes products used in neurosurgery, reconstruction, wound and dental care, made a "binding offer" for the Codman business, which will bolster its pipeline of offerings for tissue ablation, spinal cord repair and cranial stabilization. The companies will finalize the deal after receiving the green light from various works councils and regulators, a J&J spokeswoman told Reuters, adding that the deal would close in the fourth quarter, if approved.
- TheStreet.com•7 days ago
The company hopes the JNJ assets will give revenue growth a boost.
- The Wall Street Journal•7 days ago
Integra LifeSciences Holdings has made an offer to buy Johnson & Johnson’s Codman Neurosurgery business for about $1.05 billion in cash.
IART : Summary for Integra LifeSciences Holdings C - Yahoo Finance
Integra LifeSciences Holdings Corporation (IART)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||42.85 x 300|
|Ask||44.58 x 100|
|Day's Range||43.17 - 44.02|
|52 Week Range||40.77 - 88.86|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||56.33|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|